(1) Management of allogeneic HCT is a complex endeavor involving donors and donor centers, cell collection centers, cord blood and HSC banks and transplant centers. HCT implies pretransplant planning, donor and cell product management, transplant procedures and long-term follow-up. Different but overlapping data sets are collected for organizational, communicational and scientific purposes and patient data are entered repeatedly into electronic medical files, specialized local databases and (inter)national registries and reproduced on multiple paper forms. The challenge is to transform an inefficient and error-prone system into a unique IT tool satisfying all local needs and international and regulatory/quality requirements. This management software would be a ground-breaking development, enhancing QM of this activity to the benefit of patient.
- CHU has internally developed the structural and functional characteristics of an extensive stand-alone IT tool to manage various aspects of HCT (i.e. data integration, automatic transmission of forms, electronic export to registries…).
(2) Obtaining accreditation of transplant activity by the Joint Accreditation Committee of ISCT and EBMT (JACIE) is associated with better outcomes (including overall survival) in patients. Jessa, CHU and MUMC have obtained the JACIE accreditation and our objective is to
- Facilitate JACIE accreditation of ECCA by providing strong support for all preparation steps.